CAT. NO.: AMA-0430
Target Information | |
---|---|
UniProt ID | P11802 |
Product Details | |
---|---|
Size | 20 µL/100 µL |
Reactivity | Human, Monkey |
Host | Rabbit |
Source/Isotype | Rabbit IgG |
Storage | Store at -20°C. Do not aliquot the antibody. |
Purification | Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy terminus of human CDK4 protein. |
Usage | |
---|---|
Application | WB, IHC, IF, F |
Product Usage Information Dilution | Western Blotting (1:1000); Immunohistochemistry (1:400-1:1600); Immunohistochemistry (1:200-1:800); Flow Cytometry (1:100-1:400) |
MW (Target) | 30 kDa |
Background | |
---|---|
Cyclin-dependent kinase activity is regulated by T-loop phosphorylation (Thr172 in the case of CDK4), by the abundance of their cyclin partners, and by association with CDK inhibitors of the Cip/Kip or INK family of proteins The inactive ternary complex of CDK4/cyclin D and p27 Kip1/Cip1 requires extracellular mitogenic stimuli for the release and degradation of p27, which affects progression through the restriction point and pRb-dependent entry into S-phase The active complex of CDK4/cyclin D targets the retinoblastoma protein for phosphorylation, allowing the release of E2F transcription factors that activate G1/S-phase gene expression In HeLa cells, upon UV irradiation, upregulation of p16 INK4A association with CDK4/cyclin D3 leads to a G2 delay, implicating CDK4/cyclin D3 activity in progression through the G2-phase of the cell cycle. |
Our customers have direct access to our experts and give timely feedback to any online inquiries. If you are interested in our products, please contact us.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.